HealthcareServices

Neurodiagnostics Industry Insights: Market Forecast to 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Neurodiagnostics Market Expected To Become By 2029 Compared With Its 2025 Level?

The neurodiagnostics market has experienced robust growth in recent years. It is projected to expand from $9.17 billion in 2024 to $9.79 billion in 2025, at a compound annual growth rate (CAGR) of 6.8%. This historical expansion can be attributed to factors such as an increased prevalence of neurological disorders, a rise in the adoption of advanced imaging technologies, an expanding geriatric population, greater awareness of early disease diagnosis, the development of healthcare infrastructure, and heightened investments in neuroscience research and development.

The neurodiagnostics market is projected for significant expansion over the coming years, with its value anticipated to reach $12.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period is propelled by factors such as a heightened demand for non-invasive diagnostic methods, the escalating occurrence of neurological disorders, increased government spending on healthcare infrastructure, greater awareness and early detection programs, and the broadening of personalized medicine strategies. Key trends expected within this period encompass the creation of portable EEG devices, the incorporation of AI to boost diagnostic precision, advancements in MRI technologies for brain imaging, the use of wearables for ongoing monitoring, progress in neurogenetic testing, and the implementation of real-time data analytics for customized treatment regimens.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20902&type=smp

Which Drivers Are Shaping The Neurodiagnostics Industry’s Market Share?

The expanding occurrence of neurological disorders is projected to propel the development of the neurodiagnostics market in the future. These conditions involve affections of the brain, spinal cord, or nerves, resulting in diverse cognitive, motor, and sensory deficits. The escalation in neurological disorders primarily stems from an aging demographic, environmental influences, alterations in lifestyle, genetic predispositions, and improved diagnostic methodologies. Neurodiagnostics play a crucial role in the accurate identification, evaluation, and tracking of neurological disorders, thereby facilitating exact diagnoses, well-informed treatment choices, and efficient handling of conditions impacting the brain, spinal cord, and nerves. As an illustration, the National Library of Medicine, a US-based medical library for medical research information, reported in April 2023 that 6.7 million Americans were suffering from Alzheimer’s in 2023, with projections indicating an increase to 13.8 million by 2060. Consequently, the rising incidence of neurological disorders is stimulating the expansion of the neurodiagnostics market.

How Is The Neurodiagnostics Market Segmented?

The neurodiagnosticsmarket covered in this report is segmented –

1) By Type: Diagnostic And Imaging Solutions; In-Vitro Diagnostics

2) By Technology: Neuroimaging Technologies; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Nuclear Medicine Imaging (PET, SPECT); Near Infrared Spectroscopic Imaging (NIRS); Electro-Encephalography (EEG); Magneto-Encephalography (MEG); Voxel Based Morphometry (VBM); Neuroinformatics

3) By Condition: Epilepsy; Alzheimer’s Disease; Parkinson’s Disease; Stroke; Joint Health; Other Conditions

4) By End Use : Hospitals And Clinics; Diagnostic Laboratories; Imaging Centers; Other End Uses

Subsegments:

1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems; CT (Computed Tomography) Scanners; EEG (Electroencephalogram) Systems; EMG (Electromyography) Systems; MEG (Magnetoencephalography) Systems; PET (Positron Emission Tomography) Scanners; SPECT (Single Photon Emission Computed Tomography) Scanners; Functional MRI (fMRI) Systems; Intracranial Pressure Monitors

2) By In-Vitro Diagnostics: Blood-Based Diagnostics; Cerebrospinal Fluid (Csf) Analysis; Genetic Testing And Biomarkers; Neurochemical Diagnostics; Point-Of-Care Neurodiagnostics; Diagnostic Kits For Neurodegenerative Disorders

Which Trends Are Impacting The Neurodiagnostics Market?

Key companies within the neurodiagnostics market are emphasizing technological advancements, particularly advanced software algorithms, to elevate diagnostic precision and achieve better patient outcomes. An advanced software algorithm is defined as an intricate framework of instructions that processes and analyzes data, often employing techniques such such as artificial intelligence (AI) or machine learning, to refine decision-making and diagnostic processes. For instance, in October 2023, Ceribell Inc., a US-based medical equipment manufacturing firm, launched its ClarityPro AI algorithm, representing a significant stride in the diagnosis of electrographic status epilepticus (ESE). This sophisticated software, integrated into the Ceribell EEG system, utilizes machine learning to analyze EEG waveforms and deliver real-time notifications for potential seizures. Notably, ClarityPro is the initial acute care device to obtain FDA clearance for independent diagnostic use. This groundbreaking technology is designed to improve clinical judgment by constantly monitoring brain activity, providing actionable data, and enabling faster, more effective treatment interventions.

Who Are The Key Multinational Companies Dominating The Neurodiagnostics Market?

Major companies operating in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neurodiagnostics-global-market-report

What Are The Regional Market Dynamics Impacting The Neurodiagnostics Industry?

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Neurodiagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20902&type=smp

Browse Through More Reports Similar to the Global Neurodiagnostics Market 2025, By The Business Research Company

Neuroprosthetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroprosthetics-global-market-report

Neuroscience Antibodies And Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

Neuroscience Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroscience-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795